Intercept Pharmaceuticals | Satış Ve Yönetim Giderleri

Selling And Administration Expenses Değişiklik Tarih
Acadia Pharmaceuticals USD 111.46M 13.58M 2023-12
Alnylam Pharmaceuticals USD 198.12M 1.05M 2023-12
Amarin USD 45.46M 5.5M 2023-09
Amgen USD 1.76B 424M 2023-12
Arrowhead Research USD 26.19M 595K 2023-12
AstraZeneca USD 3.91B 194M 2023-09
Bristol-Myers Squibb USD 2.06B 126M 2023-12
Eli Lilly USD 1.92B 120.7M 2023-12
Gilead Sciences USD 1.61B 293M 2023-12
GlaxoSmithKline GBP 2.18B 6M 2023-09
Incyte USD 293.86M 25.97M 2023-12
Ionis Pharmaceuticals USD 71.01M 1.06M 2023-12
Moderna USD 470M 28M 2023-12
Neurocrine Biosciences USD 204.2M 17.6M 2023-09
PTC Therapeutics USD 76.29M 4.6M 2023-12
Regeneron Pharmaceuticals USD 737.7M 97.2M 2023-12
Sarepta Therapeutics USD 120.89M 2.33M 2023-09
Vertex Pharmaceuticals USD 263.8M 1.2M 2023-09



Intercept Pharmaceuticals Satış Ve Yönetim Giderleri - Akım değerleri, tarihsel veriler, tahminler, istatistikler, grafikler ve ekonomik takvim - Apr 2024.